Search - tctmd.com

Displaying 481 - 500 of 699

Sort: Relevancy | Date

News Daily News

Serial CTA Shines a Light on Statin Effects in Subclinical CAD

Yael L. Maxwell

June 15, 2018

News Daily News

Do Not Screen Asymptomatic Adults For CVD With ECGs, Says USPSTF

Michael O'Riordan

June 12, 2018

News Daily News

Obesity Not Benign: Higher Risk of CVD Seen With Excess Weight

Michael O'Riordan

June 05, 2018

News Daily News

Biomarkers, New Data, and Revised Methods Boost Accuracy of the ACC/AHA Risk Equations

Todd Neale

June 04, 2018

News Conference News EAS 2018

Glucose and Beyond? Experts Debate Optimal Targets for Managing CV Risk in Diabetics

Yael L. Maxwell

May 16, 2018

News Conference News EAS 2018

ORION 1 Data Show Lipoprotein-Lowering Beyond LDL Cholesterol With Injectable Inclisiran

Yael L. Maxwell

May 14, 2018

News Conference News EAS 2018

EAS Consensus Document Examines Safety of Statins Beyond Muscle Symptoms

Yael L. Maxwell

May 11, 2018

News Conference News HRS 2018

Increasing Air Pollution May Spark Sudden Cardiac Death in Women

Todd Neale

May 09, 2018

News Conference News EAS 2018

Unlocking Lp(a): Baseline Levels Matter, but So Too Does Absolute Reduction

Yael L. Maxwell

May 08, 2018

Podcast Heart Sounds

Number of Cigarettes Smoked per Day Influences Stroke Risk in Young Men

L.A. McKeown

April 19, 2018

News Daily News

New Biomarker on the Block, FGF-23, May Aid in Secondary-Event Prediction Following ACS

Yael L. Maxwell

April 18, 2018

News Daily News

Particulate Matter From California Wildfires Linked to Cardiovascular and Cerebrovascular Events

L.A. McKeown

April 12, 2018

News Daily News

FDA’s Proposed Sodium Reduction Plan Could Have a Big Impact, Analysis Suggests

Todd Neale

April 11, 2018

News Daily News

Outrunning Your Genes: Exercise Offsets CVD Events Among High-Risk Subjects

Michael O'Riordan

April 10, 2018

News Daily News

More Awareness of Familial Hypercholesterolemia and Severe Dyslipidemia, yet Statin Use Remains Low

Yael L. Maxwell

March 28, 2018

News Conference News ACC 2018

High CRP Linked to Bigger Absolute Drops in CV Events for Patients Taking Evolocumab

Michael O'Riordan

March 20, 2018

News Conference News ACC 2018

Perioperative Beta-blockade for Noncardiac Surgery Increases Death, Stroke at 1 Year

Yael L. Maxwell

March 15, 2018

News Conference News ACC 2018

Precision Medicine Gamble Fails for CETP Inhibitors in ACCELERATE Analysis

Michael O'Riordan

March 14, 2018

News Conference News ACC 2018

ODYSSEY Delivers a Win for Alirocumab in ACS, With a Signal of Survival Benefit

Michael O'Riordan

March 10, 2018

Advertisement

Serial CTA Shines a Light on Statin Effects in Subclinical CAD

Do Not Screen Asymptomatic Adults For CVD With ECGs, Says USPSTF

Obesity Not Benign: Higher Risk of CVD Seen With Excess Weight

Biomarkers, New Data, and Revised Methods Boost Accuracy of the ACC/AHA Risk Equations

Glucose and Beyond? Experts Debate Optimal Targets for Managing CV Risk in Diabetics

ORION 1 Data Show Lipoprotein-Lowering Beyond LDL Cholesterol With Injectable Inclisiran

EAS Consensus Document Examines Safety of Statins Beyond Muscle Symptoms

Increasing Air Pollution May Spark Sudden Cardiac Death in Women

Unlocking Lp(a): Baseline Levels Matter, but So Too Does Absolute Reduction

Top Stories in Cardiology: April 2018

Number of Cigarettes Smoked per Day Influences Stroke Risk in Young Men

New Biomarker on the Block, FGF-23, May Aid in Secondary-Event Prediction Following ACS

Particulate Matter From California Wildfires Linked to Cardiovascular and Cerebrovascular Events

FDA’s Proposed Sodium Reduction Plan Could Have a Big Impact, Analysis Suggests

Outrunning Your Genes: Exercise Offsets CVD Events Among High-Risk Subjects

More Awareness of Familial Hypercholesterolemia and Severe Dyslipidemia, yet Statin Use Remains Low

High CRP Linked to Bigger Absolute Drops in CV Events for Patients Taking Evolocumab

Perioperative Beta-blockade for Noncardiac Surgery Increases Death, Stroke at 1 Year

Precision Medicine Gamble Fails for CETP Inhibitors in ACCELERATE Analysis

ODYSSEY Delivers a Win for Alirocumab in ACS, With a Signal of Survival Benefit

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content